AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28
Globe Newswire • Wed Feb 26 2025
BERWYN, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, reaffirms its commitment to supporting the 300 million individuals worldwide affected by rare diseases. In recognition of Rare Disease Day, held annually on the last day of February, the AscellaHealth team participates in this global initiative to raise awareness about rare diseases and highlight the strength and unity within these communities.
BERWYN, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) – AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, reaffirms its commitment to supporting the 300 million individuals worldwide affected by rare diseases. In recognition of Rare Disease Day, held annually on the last day of February, the AscellaHealth team participates in this global initiative to raise awareness about rare diseases and highlight the strength and unity within these communities. Emphasizing the need for equitable access to care, AscellaHealth acknowledges that over 6,000 rare diseases are known, 72% of which are genetic, and 70% of genetic rare diseases begin in childhood.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.